Boule Diagnostics AB (BOUL) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Boule Diagnostics Ab.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.071 -- 00:00:03.952 Good morning and welcome to our Q2 00:00:04.534 -- 00:00:07.955 2026 earnings calls. My name is Michael Avinklefelt. 00:00:07.955 -- 00:00:13.799 I'm the CFO of Bull Diagnostics. And with me today, I have our new CEO, Johan Folkkunger, 00:00:13.799 -- 00:00:18.902 who joins us for his first investor call. We will be recording this session and after 00:00:18.902 -- 00:00:24.105 the formal presentation, we will open up for questions on the line and in the chat. 00:00:24.105 -- 00:00:27.467 With that, I hand it over to you, Johan. 00:00:27.467 -- 00:00:32.723 Thank you, Michael. So starting my new position on June 22nd, 00:00:32.723 -- 00:00:36.245 I have now been with the company for three weeks. 00:00:36.245 -- 00:00:41.848 I've spent this time familiarizing with the business and the organization to define priorities 00:00:41.848 -- 00:00:43.750 going forward. 00:00:43.750 -- 00:00:48.552 Despite the short time in the company, I'm impressed by the competence and commitment 00:00:48.552 -- 00:00:53.795 in the organization. There is a strong pride and engagement to continue the transformation 00:00:53.795 -- 00:00:57.560 to serve our markets and strengthen our business. 00:00:57.560 -- 00:01:02.302 In the near term, I will continue familiarising myself with the company and look forward 00:01:02.302 -- 00:01:07.304 to working together with the board of directors, management and employees to drive the 00:01:07.304 -- 00:01:11.645 transformation journey the company is going through. 00:01:11.946 -- 00:01:16.968 So let's look back at the second quarter, and I will conclude it has been a quarter 00:01:16.968 -- 00:01:22.830 characterised by a challenging market environment and geopolitical disruptions. 00:01:22.830 -- 00:01:28.200 And as w...